J Cancer 2019; 10(5):1307-1312. doi:10.7150/jca.28320 This issue Cite

Research Paper

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study

Dakui Luo1,3, Qi Liu1,3, Ji Zhu2,3, Yanlei Ma1,3, Sanjun Cai1,3, Qingguo Li1,3✉, Xinxiang Li1,3✉

1. Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2. Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China
3. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
Dakui Luo and Qi Liu contributed equally to this work.

Citation:
Luo D, Liu Q, Zhu J, Ma Y, Cai S, Li Q, Li X. Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study. J Cancer 2019; 10(5):1307-1312. doi:10.7150/jca.28320. https://www.jcancer.org/v10p1307.htm
Other styles

File import instruction

Abstract

Preoperative chemoradiation followed by surgery has been recommended as a standard treatment for patients with stage II/III rectal cancer. However, the optimal sequencing of radiotherapy for metastatic rectal cancer remains unclear. Between 2004 and 2014, patients diagnosed with metastatic rectal cancer who underwent the resection of primary site and received radiotherapy were retrospectively selected using the Surveillance, Epidemiology, and End Results (SEER) database. The propensity score matching analyses were used to lessen the effects of confounding factors including age, sex, race, marital status, serum carcinoembryonic antigen level, histologic type, differentiation status, tumor size, T stage, N stage and resection of the distant lesions. The cancer-specific survival (CSS) were compared based on the sequencing of radiotherapy. Ultimately, 686 matched pairs were formed for comparison of preoperative versus postoperative radiotherapy. The 5-year CSS estimates were 33.4% (95% CI: 28.9%-37.9%) and 26.8% (95% CI: 22.7%-30.9%) for patients underwent preoperative radiotherapy followed by resection of primary lesion and postoperative radiotherapy after surgery, respectively. Patients underwent preoperative radiotherapy had better CSS as compared to patients received postoperative radiotherapy (p<0.001 for log-rank test). Multivariate analysis demonstrated that preoperative radiotherapy group was associated with significantly decreased risk for cancer death (HR=0.820, 95% CI: 0.712-0.945, p=0.006). Preoperative radiotherapy was superior to postoperative radiotherapy in patients with metastatic rectal cancer. Therapeutic strategy for these patients should be further explored.

Keywords: neoadjuvant radiotherapy, metastatic rectal cancer, propensity score matching


Citation styles

APA
Luo, D., Liu, Q., Zhu, J., Ma, Y., Cai, S., Li, Q., Li, X. (2019). Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study. Journal of Cancer, 10(5), 1307-1312. https://doi.org/10.7150/jca.28320.

ACS
Luo, D.; Liu, Q.; Zhu, J.; Ma, Y.; Cai, S.; Li, Q.; Li, X. Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study. J. Cancer 2019, 10 (5), 1307-1312. DOI: 10.7150/jca.28320.

NLM
Luo D, Liu Q, Zhu J, Ma Y, Cai S, Li Q, Li X. Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study. J Cancer 2019; 10(5):1307-1312. doi:10.7150/jca.28320. https://www.jcancer.org/v10p1307.htm

CSE
Luo D, Liu Q, Zhu J, Ma Y, Cai S, Li Q, Li X. 2019. Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study. J Cancer. 10(5):1307-1312.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image